Commitment COM-023
Post-approval commitment for PMDA-2022-0023. Category: Risk Management. Priority: low.
Commitment ID
COM-023
Application
Authority
Pharmaceuticals and Medical Devices Agency
Category
Risk Management
Priority
low
Status
In Progress
Due Date
2024-12-24
Completed At
—
Owner
Nadia Petrova
Created
2022-10-28
Description
Provide carcinogenicity study report for 2-year rat study
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.